An observational study of the discrediting of COX-2 NSAIDs in Australia: Vioxx or class effect?

<p>Abstract</p> <p>Background</p> <p>When a medicine such as rofecoxib (Vioxx) is withdrawn, or a whole class of medicines discredited such as the selective COX-2 inhibitors (COX-2s), follow-up of impacts at consumer level can be difficult and costly. The Australian Lon...

Full description

Bibliographic Details
Main Authors: Parkinson Lynne, Doljagore Xenia, Gibson Richard, Doran Evan, Notley Lisa, Stewart Williams Jenny, Kowal Paul, Byles Julie E
Format: Article
Language:English
Published: BMC 2011-11-01
Series:BMC Public Health
Online Access:http://www.biomedcentral.com/1471-2458/11/892

Similar Items